CareFusion, has signed an exclusive agreement with ResMed to distribute its AirLife line of high-flow, nasal interface oxygen therapy products.
“This collaboration will help ensure our customers have access to a full portfolio of leading respiratory solutions,” said Dan Woolson, president of Respiratory Solutions at BD.
The agreement with ResMed includes exclusive distribution rights for its AcuCare high-flow nasal cannula in the U.S. acute care market. ResMed’s nasal cannula offers a fast and intuitive fit, and is engineered to stay in place once fitted, providing speed and stability for built-in success in high flow oxygen therapy.
“The combination of ResMed products with AirLife’s reach will help provide more patients with innovative respiratory technology,” said Jim Hollingshead, president ResMed Americas. “This collaboration helps position ResMed for growth beyond what we could achieve alone.”
Additional terms of the agreement were not disclosed.